-
So yet another result that the organisers hope will come out of the road trials is some way of simplifying this electronic control system.
ECONOMIST: Fuel cells hit the road | The
-
The long delay in getting the ENHANCE out is likely to raise questions about how much control drug companies should have over the conduct of their clinical trials.
FORBES: Vytorin Study Shows No Benefit
-
The long delay to getting the Enhance study out is likely to raise questions about how much control drug companies should have over the conduct of their clinical trials.
FORBES: Magazine Article
-
While high-end evaluation methods like randomized control trials (RCTs) are the surest means of determining what interventions in fact cause certain outcomes, they are also time-consuming and costly and beyond the means of many, if not most, mainstream nonprofits.
FORBES: An Interview with Paul Carttar, Director of the Social Innovation Fund
-
In 2002 the Institute of Medicine (which is not part of the NIH, but is the health arm of the National Academy of Sciences) called for the creation of a National Vaccine Authority that would have sweeping responsibilities, including market research, the establishment of priorities, control of intellectual-property rights, the conduct of in-house research and development and the financing of clinical trials of candidate vaccines.
FORBES: Commentary